After finishing at $6.07 in the prior trading day, Annexon Inc (NASDAQ: ANNX) closed at $5.98, down -1.48%. On the day, 1300955 shares were traded.
Ratios:
Our goal is to gain a better understanding of ANNX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.72 and its Current Ratio is at 14.72. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.12.
On December 21, 2023, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $4 to $6.
On October 30, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $11.Wells Fargo initiated its Overweight rating on October 30, 2023, with a $11 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 08 ’24 when Carson William H. bought 3,200 shares for $6.07 per share. The transaction valued at 19,411 led to the insider holds 3,200 shares of the business.
Yednock Ted sold 2,604 shares of ANNX for $14,348 on Feb 20 ’24. The EVP & CHIEF INNOVATION OFFICER now owns 72,471 shares after completing the transaction at $5.51 per share. On Feb 20 ’24, another insider, Lew Jennifer, who serves as the EVP & CHIEF FINANCIAL OFFICER of the company, sold 2,593 shares for $5.53 each. As a result, the insider received 14,339 and left with 82,058 shares of the company.
Stock Price History:
Over the past 52 weeks, ANNX has reached a high of $8.40, while it has fallen to a 52-week low of $1.57.
Shares Statistics:
A total of 105.09M shares are outstanding, with a floating share count of 82.76M. Insiders hold about 21.24% of the company’s shares, while institutions hold 66.36% stake in the company.
Earnings Estimates
Its stock is currently analyzed by Annexon, Inc. different market analysts. The consensus estimate for the next quarter is $2.74, with high estimates of $3.17 and low estimates of $67.60.
Analysts are recommending an EPS of between $Healthcare and $Healthcare for the fiscal current year, implying an average EPS of $Healthcare.
